Analysis of medication use in sample pediatric hospitals
10.12206/j.issn.2097-2024.202404071
- VernacularTitle:多家儿童专科医院用药情况分析
- Author:
Yue DU
1
;
Jiali LI
1
;
Yu CHAI
1
;
Shaoqing CHEN
1
;
Qi ZHAN
1
Author Information
1. Department of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China.
- Publication Type:Pharmacyadministration
- Keywords:
medication for children;
essential medicines;
national reimbursement drug list;
the expense of medication for children;
amount of medication for children
- From:
Journal of Pharmaceutical Practice and Service
2025;43(12):631-636
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the usage of pediatric drugs in 17 pediatric specialty hospitals from 2016 to 2020, and provide reference and guidance for the development of the essential medicine list （EML） for children and the improvement of the National Reimbursement Drug List （NRDL） in China. Methods Based on the pediatric medication monitoring data from 17 children's specialized hospitals reported to the Chinese Medical Economic Information Network (CMEI) of the Chinese Pharmaceutical Association between 2016 and 2020, this study analyzes the overall situation of the sample hospitals and the clinical use of pediatric drugs according to the major categories of the Anatomical Therapeutic Chemical Classification System （ATC）. Results In the various ATC categories, the trend of systemic use of anti-infective drugs decreasing was significant in the average hospital expenditure, while the trend of respiratory and digestive system and metabolic drugs decreasing was significant in the average hospital DDDS. In 2020, the average number of hospital grade standards for essential drugs （2018 version） accounted for 15.82% of the total number of drug use standards, while the average number of hospital grade standards for medical insurance （2019 version） accounted for 8.23% of the total number of drug use standards. Conclusion The use of pediatric medication in sample hospitals from 2016 to 2020 was generally reasonable, and there would still a certain gap between the actual clinical usage habits with the existing EML and NRDL，which still need to be adjusted.
